Supernus Pharmaceuticals Files Q1 2025 10-Q
Ticker: SUPN · Form: 10-Q · Filed: May 6, 2025 · CIK: 1356576
| Field | Detail |
|---|---|
| Company | Supernus Pharmaceuticals, Inc. (SUPN) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: SUPN
TL;DR
SUPN Q1 2025 10-Q is in. Check financials.
AI Summary
Supernus Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results for the first quarter of 2025. Key financial data and operational updates are detailed within the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Supernus Pharmaceuticals, Inc., crucial for understanding the company's trajectory in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Supernus is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the beginning of the fiscal quarter for which financial information is reported.)
- 2024-12-31 — Prior Fiscal Year End Date (Provides a point of comparison for financial performance.)
Key Players & Entities
- SUPERNUS PHARMACEUTICALS, INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250506 (date) — Filing Date
- 2834 (other) — Standard Industrial Classification Code
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 6, 2025.
What is Supernus Pharmaceuticals, Inc.'s Standard Industrial Classification code?
Supernus Pharmaceuticals, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end date?
The company's fiscal year end date is December 31.
What are the key dates associated with the reporting period?
The reporting period starts on January 1, 2025, and ends on March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding SUPERNUS PHARMACEUTICALS, INC. (SUPN).